- Compositionlorlatinib
- TypeTablet
- Supply TypeManufacturer
- Preferred Buyer Location All over the world
Lorlatinib (Lorviqua) Lorlatinib is a type of targeted cancer drug . It is pronounced lor-la-tih-nib. Lorlatinib is a treatment for non small cell lung cancer with an anaplastic lymphoma kinase (ALK) gene change. It is also called ALK positive non small cell lung cancer.
View More Details